US20090298143A1 - Secretion of fatty acids by photosynthetic microorganisms - Google Patents

Secretion of fatty acids by photosynthetic microorganisms Download PDF

Info

Publication number
US20090298143A1
US20090298143A1 US12/333,280 US33328008A US2009298143A1 US 20090298143 A1 US20090298143 A1 US 20090298143A1 US 33328008 A US33328008 A US 33328008A US 2009298143 A1 US2009298143 A1 US 2009298143A1
Authority
US
United States
Prior art keywords
culture
acyl
fatty acids
medium
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/333,280
Other languages
English (en)
Inventor
Paul Gordon ROESSLER
You Chen
Bo Liu
Corey Neal Dodge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viridos Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/333,280 priority Critical patent/US20090298143A1/en
Assigned to SYNTHETIC GENOMICS, INC. reassignment SYNTHETIC GENOMICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHEN, You, DODGE, COREY N, LIU, BO, ROESSLER, PAUL G
Publication of US20090298143A1 publication Critical patent/US20090298143A1/en
Priority to US13/340,350 priority patent/US10233470B2/en
Assigned to OXFORD FINANCE LLC reassignment OXFORD FINANCE LLC SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SYNTHETIC GENOMICS, INC.
Assigned to GENOVIA BIO, LLC, GREEN RESOURCES, LLC, SYNTHETIC GENOMICS VACCINES, INC., SYNTHETIC GENOMICS, INC., SGI-DNA, INC. reassignment GENOVIA BIO, LLC RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: OXFORD FINANCE LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/649—Biodiesel, i.e. fatty acid alkyl esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02T—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO TRANSPORTATION
    • Y02T50/00—Aeronautics or air transport
    • Y02T50/60—Efficient propulsion technologies, e.g. for aircraft
    • Y02T50/678—Aviation using fuels of non-fossil origin

Definitions

  • This invention relates to photosynthetic microorganisms that convert inorganic carbon to fatty acids and secrete them into the culture medium, methods of production of fatty acids using such organisms, and uses thereof.
  • the fatty acids may be used directly or may be further modified to alternate forms such as esters, reduced forms such as alcohols, or hydrocarbons, for applications in different industries, including fuels and chemicals.
  • Photosynthetic microorganisms including eukaryotic algae and cyanobacteria, contain various lipids, including polar lipids and neutral lipids.
  • Polar lipids e.g., phospholipids, glycolipids, sulfolipids
  • neutral lipids e.g., triacylglycerols, wax esters
  • a substantial research effort has been devoted to the development of methods to produce lipid-based fuels and chemicals from photosynthetic microorganisms.
  • eukaryotic microalgae are grown under nutrient-replete conditions until a certain cell density is achieved, after which the cells are subjected to growth under nutrient-deficient conditions, which often leads to the accumulation of neutral lipids.
  • the cells are then harvested by various means (e.g., settling, which can be facilitated by the addition of flocculants, followed by centrifugation), dried, and then the lipids are extracted from the cells by the use of various non-polar solvents.
  • Harvesting of the cells and extraction of the lipids are cost-intensive steps. It would be desirable to obtain lipids from photosynthetic microorganisms without the requirement for cell harvesting and extraction.
  • PCT publication numbers WO2007/136762 and WO2008/119082 describe the production of biofuel components using microorganisms. These documents disclose the production by these organisms of fatty acid derivatives which are, apparently, short and long chain alcohols, hydrocarbons, fatty alcohols and esters including waxes, fatty acid esters or fatty esters. To the extent that fatty acid production is described, it is proposed as an intermediate to these derivatives, and the fatty acids are therefore not secreted. Further, there is no disclosure of converting inorganic carbon directly to secreted fatty acids using a photosynthetic organism grown in a culture medium containing inorganic carbon as the primary carbon source. The present invention takes advantage of the efficiency of photosynthetic organisms in secreting fatty acids into the medium in order to recover these valuable compounds.
  • the invention includes the expression of heterologous acyl-ACP thioesterase (TE) genes in photosynthetic microbes. Many of these genes, along with their use to alter lipid metabolism in oilseeds, have been described previously. Genes encoding the proteins that catalyze various steps in the synthesis and further metabolism of fatty acids have also been extensively described.
  • TE heterologous acyl-ACP thioesterase
  • acyl-ACP thioesterases unsaturated fatty acid-recognizing Fat A versus saturated fatty acid-recognizing FatB
  • FatAs show marked preference for 18:1-ACP with minor activity towards 18:0- and 16:0-ACPs
  • FatBs hydrolyze primarily saturated acyl-ACPs with chain lengths that vary between 8-16 carbons.
  • fatty acid synthetase catalyzes a repeating cycle wherein malonyl-acyl carrier protein (ACP) is condensed with a substrate, initially acetyl-CoA, to form acetoacetyl-ACP, liberating CO 2 .
  • ACP malonyl-acyl carrier protein
  • the acetoacetyl-ACP is then reduced, dehydrated, and reduced further to butyryl-ACP which can then itself be condensed with malonyl-ACP, and the cycle repeated, adding a 2-carbon unit at each turn.
  • the production of free fatty acids would therefore be enhanced by a thioesterase that would liberate the fatty acid itself from ACP, breaking the cycle.
  • the acyl-ACP is prevented from reentering the cycle. Production of the fatty acid would also be encouraged by enhancing the levels of fatty acid synthetase and inhibiting any enzymes which result in degradation or further metabolism of the fatty acid.
  • FIG. 2 presents a more detailed description of the sequential formation of acyl-ACPs of longer and longer chains. As shown, the thioesterase enzymes listed in FIG. 2 liberate the fatty acid from the ACP thioester.
  • the present invention is directed to the production of recombinant photosynthetic microorganisms that are able to secrete fatty acids derived from inorganic carbon into the culture medium. Methods to remove the secreted fatty acids from the culture medium without the need for cell harvesting are also provided. It is anticipated that these improvements will lead to lower costs for producing lipid-based fuels and chemicals from photosynthetic microorganisms. In addition, this invention enables the production of fatty acids of defined chain length, thus allowing their use in the formulation of a variety of different products, including fuels and chemicals.
  • Carbon dioxide (which, along with carbonic acid, bicarbonate and/or carbonate define the term “inorganic carbon”) is converted in the photosynthetic process to organic compounds.
  • the inorganic carbon source includes any way of delivering inorganic carbon, optionally in admixture with any other combination of compounds which do not serve as the primary carbon feedstock, but only as a mixture or carrier (for example, emissions from biofuel (e.g., ethanol) plants, power plants, petroleum-based refineries, as well as atmospheric and subterranean sources).
  • biofuel e.g., ethanol
  • One embodiment of the invention relates to a culture of recombinant photosynthetic microorganisms, said organisms comprising at least one recombinant expression vector encoding at least one exogenous acyl-ACP thioesterase, wherein the at least one exogenous acyl-ACP thioesterase preferentially liberates fatty acid chains containing 6 to 20 carbons from these ACP thioesters.
  • the fatty acids are formed from inorganic carbon as their carbon source and the culture contains substantially only inorganic carbon as a carbon source.
  • the presence of the exogenous thioesterase will increase the secretion levels of desired fatty acids by at least 2-4 fold.
  • the invention is directed to a cell culture of a recombinant photosynthetic microorganism where the microorganism has been modified to contain a nucleic acid molecule comprising at least one recombinant expression system that produces at least one exogenous acyl-ACP thioesterase, wherein said acyl-ACP thioesterase preferentially liberates a fatty acid chain that contains 6-20 carbons, and wherein the culture medium provides inorganic carbon as substantially the sole carbon source and wherein said microorganism secretes the fatty acid liberated by the acyl-ACP thioesterase into the medium.
  • the thioesterase preferentially liberates a fatty acid chain that contains 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 carbons.
  • the invention is directed to a method to produce fatty acids of desired chain lengths by incubating these cultures and recovering these secreted fatty acids from the cultures.
  • the recovery employs solid particulate adsorbents to harvest the secreted fatty acids.
  • the fatty acids thus recovered can be further modified synthetically or used directly as components of biofuels or chemicals.
  • FIG. 1 is a diagram of the pathway of fatty acid synthesis as is known in the art.
  • FIG. 2 is a more detailed diagram of the synthesis of fatty acids of multiple chain lengths as is known in the art.
  • FIG. 3 is an enzymatic overview of fatty acid biosynthesis identifying enzymatic classes for the production of various chain length fatty acids.
  • FIG. 4 is a schematic diagram of a recovery system for fatty acids from the medium.
  • FIG. 5 shows an experimental system based on the principles in FIG. 4 .
  • FIG. 6 shows representative acyl-ACP thioesterase from a variety of organisms.
  • the present invention provides photosynthetic microorganisms that secrete fatty acids into the culture medium, along with methods to adsorb the fatty acids from the culture medium and collect them for processing into fuels and chemicals.
  • the invention thereby eliminates or greatly reduces the need to harvest and extract the cells, resulting in substantially reduced production costs.
  • FIG. 2 is an overview of one aspect of the invention.
  • carbon dioxide is converted to acetyl-CoA using the multiple steps in the photosynthetic process.
  • the acetyl-CoA is then converted to malonyl-CoA by the action of acetyl-CoA carboxylase.
  • the malonyl-CoA is then converted to malonyl-ACP by the action of malonyl-CoA:ACP transacylase which, upon progressive action of fatty acid synthetase, results in successive additions of two carbon units.
  • the process is essentially halted at carbon chain lengths of 6 or 8 or 10 or 12 or 14 or 16 or 18 carbons by supplying the appropriate thioesterase (shown in FIG. 2 as FatB).
  • the cell biomass can be harvested as well.
  • the secreted fatty acids can be converted to various other forms including, for example, methyl esters, alkanes, alkenes, alpha-olefins and fatty alcohols.
  • the organism In order to effect secretion of the free fatty acids, the organism is provided at least one expression system for at least one thioesterase that operates preferentially to liberate fatty acids of the desired length.
  • thioesterase that operates preferentially to liberate fatty acids of the desired length.
  • Examples include U.S. Pat. No. 5,298,421, entitled “Plant medium-chain-preferring acyl-ACP thioesterases and related methods,” which describes the isolation of an acyl-ACP thioesterase and the gene that encodes it from the immature seeds of Umbellularia californica .
  • Other sources for such thioesterases and their encoding genes include U.S. Pat. No. 5,304,481, entitled “Plant thioesterase having preferential hydrolase activity toward C12 acyl-ACP substrate,” U.S. Pat. No. 5,344,771, entitled “Plant thioesterases,” U.S. Pat. No.
  • Filichkin, S., et al., European Journal of Lipid Science and Technology (2006) 108:979-990 describe “New FATB thioesterases from a high-laurate Cuphea species: Functional and complementation analyses.” Jones, A., et al., Plant Cell (1995) 7:359-371, describe “Palmitoyl-
  • acyl-ACP TEs can be isolated from plants that naturally contain large amounts of medium-chain fatty acids in their seed oil, including certain plants in the Lauraceae, Lythraceae, Rutaceae, Ulmaceae, and Vochysiaceae families.
  • the fatty acids produced by the seeds of these plants are esterified to glycerol and retained inside the cells.
  • the seeds containing the products can then be harvested and processed to isolate the fatty acids.
  • Other sources of these enzymes, such as bacteria may also be used.
  • the known acyl-ACP TEs from plants can be divided into two main classes, based on their amino acid sequences and their specificity for acyl-ACPs of differing chain lengths and degrees of unsaturation.
  • the “FatA” type of plant acyl-ACP TE has preferential activity on oleoyl-ACP, thereby releasing oleic acid, an 18-carbon fatty acid with a single double bond nine carbons distal to the carboxyl group.
  • the “FatB” type of plant acyl-ACP TE has preferential activity on saturated acyl-ACPs, and can have broad or narrow chain length specificities.
  • FatB enzymes from different species of Cuphea have been shown to release fatty acids ranging from eight carbons in length to sixteen carbons in length from the corresponding acyl-ACPs.
  • fatty acids ranging from eight carbons in length to sixteen carbons in length from the corresponding acyl-ACPs.
  • Table 1 Listed below in Table 1 are several plant acyl-ACP TEs along with their substrate preferences. (Fatty acids are designated by standard shorthand notation, wherein the number preceding the colon represents the acyl chain length and the number after the colon represents the number of double bonds in the acyl chain.)
  • acyl-ACP TEs The enzymes listed in Table 1 are exemplary and many additional genes encoding acyl-ACP TEs can be isolated and used in this invention, including but not limited to genes such as those that encode the following acyl-ACP TEs (referred to by GenPept Accession Numbers):
  • the present invention contemplates the specific production of an individual length of medium-chain fatty acid, for example, predominently producing C8 fatty acids in one culture of recombinant photosynthetic microorganisms.
  • the present invention contemplates the production of a combination of two or more different length fatty acids, for example, both C8 and C10 fatty acids in one culture of recombinant photosynthetic microorganisms.
  • the host may be modified to include an expression system for a heterologous gene that encodes a ⁇ -ketoacyl synthase (KAS) that preferentially produces acyl-ACPs having medium chain lengths.
  • KAS ⁇ -ketoacyl synthase
  • Such KAS enzymes have been described from several plants, including various species of Cuphea . See Dehesh, K., et al., The Plant Journal (1998) 15:383-390, describe “KAS IV: a 3-ketoacyl-ACP synthase from Cuphea sp.
  • the photosynthetic host cell containing a heterologous acyl-ACP TE gene may be further modified to include an expression system for a heterologous gene that encodes a multifunctional acetyl-CoA carboxylase or a set of heterologous genes that encode the various subunits of a multi-subunit type of acetyl-CoA carboxylase.
  • heterologous genes that encode additional enzymes or components of the fatty acid biosynthesis pathway could also be introduced and expressed in acyl-ACP TE-containing host cells.
  • the photosynthetic microorganism may also be modified such that one or more genes that encode beta-oxidation pathway enzymes have been inactivated or downregulated, or the enzymes themselves may be inhibited. This would prevent the degradation of fatty acids released from acyl-ACPs, thus enhancing the yield of secreted fatty acids.
  • the desired products are medium-chain fatty acids
  • the inactivation or downregulation of genes that encode acyl-CoA synthetase and/or acyl-CoA oxidase enzymes that preferentially use these chain lengths as substrates would be beneficial.
  • Mutations in the genes encoding medium-chain-specific acyl-CoA synthetase and/or medium-chain-specific acyl-CoA oxidase enzymes such that the activity of the enzymes is diminished would also be effective in increasing the yield of secreted fatty acids.
  • An additional modification inactivates or down-regulates the acyl-ACP synthetase gene or inactivates the gene or protein.
  • Mutations in the genes can be introduced either by recombinant or non-recombinant methods. These enzymes and their genes are well known, and may be targeted specifically by disruption, deletion, generation of antisense sequences, generation of ribozymes or other recombinant approaches known to the practitioner. Inactivation of the genes can also be accomplished by random mutation techniques such as UV, and the resulting cells screened for successful mutants.
  • the proteins themselves can be inhibited by intracellular generation of appropriate antibodies or intracellular generation of peptide inhibitors.
  • the photosynthetic microorganism may also be modified such that one or more genes that encode storage carbohydrate or polyhydroxyalkanoate (PHA) biosynthesis pathway enzymes have been inactivated or down-regulated, or the enzymes themselves may be inhibited.
  • PHA polyhydroxyalkanoate
  • Examples include enzymes involved in glycogen, starch, or chrysolaminarin synthesis, including glucan synthases and branching enzymes.
  • Other examples include enzymes involved in PHA biosynthesis such as acetoacetyl-CoA synthase and PHA synthase.
  • heterologous genes in cyanobacteria and eukaryotic algae is enabled by the introduction of appropriate expression vectors.
  • a variety of promoters that function in cyanobacteria can be utilized, including, but not limited to the lac, tac, and trc promoters and derivatives that are inducible by the addition of isopropyl ⁇ -D-1-thiogalactopyranoside (IPTG), promoters that are naturally associated with transposon- or bacterial chromosome-borne antibiotic resistance genes (neomycin phosphotransferase, chloramphenicol acetyltransferase, spectinomycin adenyltransferase, etc.), promoters associated with various heterologous bacterial and native cyanobacterial genes, promoters from viruses and phages, and synthetic promoters. Promoters isolated from cyanobacteria that have been used successfully include the following:
  • psbA D1 protein of PSII; light-inducible
  • transcriptional terminators can be used for expression vector construction.
  • examples of possible terminators include, but are not limited to, psbA, psaAB, rbc, secA, and T7 coat protein.
  • Expression vectors are introduced into the cyanobacterial strains by standard methods, including, but not limited to, natural DNA uptake, conjugation, electroporation, particle bombardment, and abrasion with glass beads, SiC fibers, or other particles.
  • the vectors can be: 1) targeted for integration into the cyanobacterial chromosome by including flanking sequences that enable homologous recombination into the chromosome, 2) targeted for integration into endogenous cyanobacterial plasmids by including flanking sequences that enable homologous recombination into the endogenous plasmids, or 3) designed such that the expression vectors replicate within the chosen host.
  • promoters and terminators that function in green algae can be utilized, including, but not limited to promoters and terminators from Chlamydomonas and other algae, promoters and terminators from viruses, and synthetic promoters and terminators.
  • Expression vectors are introduced into the green algal strains by standard methods, including, but not limited to, electroporation, particle bombardment, and abrasion with glass beads, SiC fibers, or other particles.
  • the vectors can be 1) targeted for site-specific integration into the green algal chloroplast chromosome by including flanking sequences that enable homologous recombination into the chromosome, or 2) targeted for integration into the cellular (nucleus-localized) chromosome.
  • promoters that function in diatoms can be utilized in these expression vectors, including, but not limited to: 1) promoters from Thalassiosira and other heterokont algae, promoters from viruses, and synthetic promoters.
  • Promoters from Thalassiosira pseudonana that would be suitable for use in expression vectors include an alpha-tubulin promoter (SEQ ID NO:1), a beta-tubulin promoter (SEQ ID NO:2), and an actin promoter (SEQ ID NO:3).
  • Promoters from Phaeodacylum tricornutum that would be suitable for use in expression vectors include an alpha-tubulin promoter (SEQ ID NO:4), a beta-tubulin promoter (SEQ ID NO:5), and an actin promoter (SEQ ID NO:6). These sequences are deduced from the genomic sequences of the relevant organisms available in public databases and are merely exemplary of the wide variety of promoters that can be used. The terminators associated with these and other genes, or particular heterologous genes can be used to stop transcription and provide the appropriate signal for polyadenylation and can be derived in a similar manner or are known in the art.
  • Expression vectors are introduced into the diatom strains by standard methods, including, but not limited to, electroporation, particle bombardment, and abrasion with glass beads, SiC fibers, or other particles.
  • the vectors can be 1) targeted for site-specific integration into the diatom chloroplast chromosome by including flanking sequences that enable homologous recombination into the chromosome, or 2) targeted for integration into the cellular (nucleus-localized) chromosome.
  • the host cells used to prepare the cultures of the invention include any photosynthetic organism which is able to convert inorganic carbon into a substrate that is in turn converted to fatty acid derivatives.
  • These organisms include prokaryotes as well as eukaryotic organisms such as algae and diatoms.
  • Host organisms include eukaryotic algae and cyanobacteria (blue-green algae).
  • Representative algae include green algae (chlorophytes), red algae, diatoms, prasinophytes, glaucophytes, chlorarachniophytes, euglenophytes, chromophytes, and dinoflagellates.
  • a number of cyanobacterial species are known and have been manipulated using molecular biological techniques, including the unicellular cyanobacteria Synechocystis sp. PCC6803 and Synechococcus elongates PCC7942, whose genomes have been completely sequenced.
  • cyanobacteria The following genera of cyanobacteria may be used: one group includes
  • Another group includes
  • Still another group includes
  • Still another group includes
  • various algae including diatoms and green algae can be employed.
  • Desirable qualities of the host strain include high potential growth rate and lipid productivity at 25-50° C., high light intensity tolerance, growth in brackish or saline water, i.e., in wide range of water types, resistance to growth inhibition by high O 2 concentrations, filamentous morphology to aid harvesting by screens; resistance to predation, ability to be flocculated (by chemicals or ‘on-demand autoflocculation’), excellent inorganic carbon uptake characteristics, virus or cyanophage-resistance, tolerance to free fatty acids or other compounds associated with the invention method, and ability to undergo metabolic engineering.
  • Metabolic engineering is facilitated by the ability to take up DNA by electroporation or conjugation, lack of a restriction system and efficient homologous recombination in the event gene replacement or gene knockouts are required.
  • the fatty acids secreted into the culture medium by the recombinant photosynthetic microorganisms described above can be recovered in a variety of ways.
  • a straightforward isolation method by partition using immiscible solvents may be employed.
  • particulate adsorbents can be employed. These may be lipophilic particulates or ion exchange resins, depending on the design of the recovery method. They may be circulating in the separated medium and then collected, or the medium may be passed over a fixed bed column, for example, a chromatographic column containing these particulates.
  • the fatty acids are then eluted from the particulate adsorbents by the use of an appropriate solvent. Evaporation of the solvent, followed by further processing of the isolated fatty acids and lipids can then be carried out to yield chemicals and fuels that can be used for a variety of commercial purposes.
  • the particulate adsorbents may have average diameters ranging from 0.5 mm to 30 mm which can be manufactured from various materials including, but not limited to, polyethylene and derivatives, polystyrene and derivatives, polyamide and derivatives, polyester and derivatives, polyurethane and derivatives, polyacrylates and derivatives, silicone and derivatives, and polysaccharide and derivatives. Certain glass and ceramic materials can also be used as the solid support component of the fat adsorbing objects.
  • the surfaces of the particulate adsorbents may be modified so that they are better able to bind fatty acids and lipids. An example of such modification is the introduction of ether-linked alkyl groups having various chain lengths, preferably 8-30 carbons. In another example, acyl chains of various lengths can be attached to the surface of the fat adsorbing objects via ester, thioester, or amide linkages.
  • the particulate adsorbents are coated with inorganic compounds known to bind fatty acids and lipids.
  • inorganic compounds known to bind fatty acids and lipids. Examples of such compounds include but are not limited to aluminum hydroxide, graphite, anthracite, and silica.
  • the particles used may also be magnetized or otherwise derivatized to facilitate recovery.
  • the particles may be coupled to one member of a binding pair and the adsorbed to a substrate containing the relevant binding partner.
  • the fatty acids may be eluted from the particulate adsorbents by the use of an appropriate solvent such as hexane or ethanol.
  • the particulate adsorbents may be reused by returning them to the culture medium or used in a regenerated column.
  • the solvent containing the dissolved fatty acids is then evaporated, leaving the fatty acids in a purified state for further conversion to chemicals and fuels.
  • the particulate adsorbents can be designed to be neutrally buoyant or positively buoyant to enhance circulation in the culture medium.
  • a continuous cycle of fatty acid removal and recovery can be implemented by utilizing the steps outlined above.
  • the recovered fatty acids may be converted to alternative organic compounds, used directly, or mixed with other components. Chemical methods for such conversions are well understood in the art, and developments of biological methods for such conversions are also contemplated
  • the present invention further contemplates a variety of compositions comprising the fatty acids produced by the recombinant photosynthetic microorganisms described herein, and uses thereof.
  • the composition may comprise the fatty acids themselves, or further derivatives of the fatty acids, such as alcohols, alkanes, and alkenes which can be generated from the fatty acids produced by the microorganisms by any methods that are known in the art, as well as by development of biological methods of conversion.
  • fatty acids may be converted to alkenes by catalytic hydrogenation and catalytic dehydration.
  • the composition may serve, for example, as a biocrude.
  • the biocrude can be processed through refineries that will convert the composition compounds to various petroleum and petrochemical replacements, including alkanes, olefins and aromatics through processes including hydrotreatment, decarboxylation, isomerization and catalytic cracking and reforming.
  • the biocrude can be also converted to ester-based fuels, such as fatty acid methyl ester (commercially known as biodiesel), through established chemical processes including transesterification and esterification.
  • derivatives of the fatty acids of the present invention include C8 chemicals, such as octanol, used in the manufacture of esters for cosmetics and flavors as well as for various medical applications, and octane, used primarily as a co-monomer in production of polyethylene.
  • C8 chemicals such as octanol
  • octane used primarily as a co-monomer in production of polyethylene.
  • Derivatives of the fatty acids of the present invention may also include C10 chemicals, such as decanol, used in the manufacture of plasticizers, surfactants and solvents, and decene, used in the manufacture of lubricants.
  • Biocrudes are biologically produced compounds or a mix of different biologically produced compounds that are used as a feedstock for refineries in replacement of, or in complement to, crude oil or other forms of petroleum.
  • these feedstocks have been pre-processed through biological, chemical, mechanical or thermal processes in order to be in a liquid state that is adequate for introduction in a petroleum refinery.
  • the fatty acids of the present invention can be a biocrude, and further processed to a biofuel composition.
  • the biofuel can then perform as a finished fuel or a fuel additive.
  • Finished fuel is defined as a chemical compound or a mix of chemical compounds (produced through chemical, thermochemical or biological routes) that is in an adequate chemical and physical state to be used directly as a neat fuel or fuel additive in an engine. In many cases, but not always, the suitability of a finished fuel for use in an engine application is determined by a specification which describes the necessary physical and chemical properties that need to be met.
  • engines are: internal combustion engine, gas turbine, steam turbine, external combustion engine, and steam boiler.
  • finished fuels include: diesel fuel to be used in a compression-ignited (diesel) internal combustion engine, jet fuel to be used in an aviation turbine, fuel oil to be used in a boiler to generate steam or in an external combustion engine, ethanol to be used in a flex-fuel engine.
  • diesel fuel to be used in a compression-ignited (diesel) internal combustion engine jet fuel to be used in an aviation turbine
  • fuel oil to be used in a boiler to generate steam or in an external combustion engine fuel oil to be used in a boiler to generate steam or in an external combustion engine
  • ethanol to be used in a flex-fuel engine.
  • ASTM standards mainly used ion the US
  • EN standards mainly used in Europe.
  • Fuel additive refers to a compound or composition that is used in combination with another fuel for a variety of reasons, which include but are not limited to complying with mandates on the use of biofuels, reducing the consumption of fossil fuel-derived products or enhancing the performance of a fuel or engine.
  • fuel additives can be used to alter the freezing/gelling point, cloud point, lubricity, viscosity, oxidative stability, ignition quality, octane level, and flash point.
  • Additives can further function as antioxidants, demulsifiers, oxygenates, thermal stability improvers, cetane improvers, stabilizers, cold flow improvers, combustion improvers, anti-foams, anti-haze additives, icing inhibitors, injector cleanliness additives, smoke suppressants, drag reducing additives, metal deactivators, dispersants, detergents, demulsifiers, dyes, markers, static dissipaters, biocides, and/or corrosion inhibitors.
  • the Cuphea hookeriana FatB2 gene encoding an acyl-ACP thioesterase (ChFatB2) enzyme was modified for optimized expression in Synechococcus elongatus PCC 7942.
  • ChFatB2 acyl-ACP thioesterase
  • the nucleotide sequence of this derivative of the ChFatB2 gene (hereafter ChFatB2-7942) is provided as SEQ ID NO:7.
  • the protein sequence encoded by this gene is provided in SEQ ID NO:8.
  • trc Two different versions of the trc promoter, trc (Egon, A., et al., Gene (1983) 25:167-178) and “enhanced trc” (hereafter trcE, from pTrcHis A, Invitrogen) were used to drive the expression of ChFatB2-7942 in S. elongatus PCC 7942.
  • the trc promoter is repressed by the Lac repressor protein encoded by the lacIq gene and can be induced by the addition of isopropyl ⁇ -D-1-thiogalactopyranoside (IPTG).
  • IPTG isopropyl ⁇ -D-1-thiogalactopyranoside
  • the trcE promoter is a derivative of trc designed to facilitate expression of eukaryotic proteins in E. coli and is also inducible by IPTG.
  • the fusion fragments of ChFatB2-7942 operably linked to trc or trcE, together with the lacIq gene, were cloned into the shuttle vector pAM2314 (Mackey, S. R., et al., Methods Mol. Biol. (2007) 362:115-129), which enables transformation of S. elongatus PCC 7942 via double homologous recombination-mediated integration into the “NS1” site of the chromosome.
  • the constructed plasmid containing the trcE::ChFatB2-7942 expression cassette and lacIq gene is designated pSGI-YC01.
  • SEQ ID NO:9 represents the sequence between and including the NS1 recombination sites of pSGI-YC01.
  • the constructed plasmid containing the trc::ChFatB2-7942 expression cassette and lacIq gene is designated pSGI-YC09.
  • SEQ ID NO: 10 represents the sequence between and including the NS1 recombination sites of pSGI-YC09.
  • Each of the plasmids pSGI-YC01 and pSGI-YC09, along with the control vector pAM2314, were introduced into wild-type S. elongatus PCC 7942 cells as described by Golden and Sherman ( J. Bacteriol . (1984) 158:36-42). Both recombinant and control strains were pre-cultivated in 100 mL of BG-11 medium supplied with spectinomycin (5 mg/L) to late-log phase (OD 730 nm 1.0) on a rotary shaker (150 rpm) at 30° C. with constant illumination (60 ⁇ E m ⁇ 2 sec ⁇ 1 ).
  • Cultures were sampled 0, 48, 96, and 168 hours after IPTG induction and then filtered through Whatman® GF/F filters using a Millipore vacuum filter manifold. Filtrates were collected in screw top culture tubes for gas chromatographic (GC) analysis.
  • GC gas chromatographic
  • Free fatty acids were separated from filtered cell cultures using liquid-liquid extraction. Five mL of the filtrate were mixed with 125 ⁇ L of 1 M H 3 PO 3 and 0.25 mL of 5 M NaCl, followed by addition of 2 mL of hexane and thorough mixing.
  • a 0.2 ⁇ l sample of the hexane was injected using a 40:1 split ratio onto a DB-FFAP column (J&W Scientific, 15 m ⁇ 250 ⁇ m ⁇ 0.25 ⁇ m), with a temperature profile starting at 150° C. for 0.5 min, then heating at 15° C./min to 230° C. and holding for 7.1 min (1.1 mL/min He).
  • the trcE::ChFatB2-7942 and trc::ChFatB2-7942 fusion fragments, together with the lacIq gene, were cloned into the shuttle vector pSGI-YC03 (SEQ ID NO:11), which enables transformation of Synechocystis sp. PCC 6803 via double homologous recombination-mediated integration into the “RS1” site of the chromosome (Williams, Methods Enzymol. (1988) 167:766-778).
  • the constructed plasmid containing the trcE::ChFatB2-7942 expression cassette and lacIq gene is designated pSGI-YC08.
  • SEQ ID NO:12 represents the sequence between and including the RS1 recombination sites of pSGI-YC08.
  • the constructed plasmid containing the trc::ChFatB2-7942 expression cassette and lacIq gene is designated pSGI-YC14.
  • SEQ ID NO:13 represents the sequence between and including the RS1 recombination sites of pSGI-YC14.
  • Cultures were sampled 0, 72, and 144 hours after IPTG induction and then filtered through Whatman® GF/B filters using a Millipore vacuum filter manifold. Filtrates were collected in screw top culture tubes for gas chromatographic (GC) analysis. Free fatty acids (FFA) were separated from the filtered culture supernatant solutions by liquid-liquid extraction.
  • GC gas chromatographic
  • the trc::ChFatB2-7942 and trcE::ChFatB2-7942 fusion fragments, together with the lacIq gene, were PCR amplified using primers RS3-3F (SEQ ID NO:14) and 4YC-rrnBter-3 (SEQ ID NO:15) from pSG1-YC14 and pSGI-YC08, respectively, and then cloned into the shuttle vector pEL17, which enables transformation of A. variabilis ATCC 29413 via double homologous recombination-mediated integration into the nifU1 locus of the chromosome (Lyons and Thiel, J. Bacteriol. (1995) 177:1570-1575).
  • the constructed plasmids are designated pSG1-YC69 and pSG1-YC70 for trc::ChFatB2-7942 and trcE::ChFatB2-7942, respectively.
  • Cultures are sampled every 72 hours and then filtered through Whatman® GF/F filters using a Millipore vacuum filter manifold. Filtrates are collected in screw top culture tubes for gas chromatographic (GC) analysis as described in Example 1.
  • GC gas chromatographic
  • Primer pairs 918-15 (SEQ ID NO: 16)/918-13 (SEQ ID NO: 17) and 918-25 (SEQ ID NO:18)/918-23 (SEQ ID NO:19) were used to amplify two DNA fragments corresponding to a 5′ portion (1-480 bp) and a 3′ portion (903-1521 bp) of the coding region of synpcc7942 — 0918, respectively.
  • the cat fragment was amplified from plasmid pAM1573 (Mackey et al., Methods Mol. Biol.
  • the resulting 2,840-bp blunt-end PCR fragment (SEQ ID NO:22) was then ligated into pUC19 (Yanisch-Perron et al., Gene 33:103-119), which has been digested with both HindIII and EcoRI to remove the multiple cloning sites and subsequently blunted with T4 DNA polymerase, to yield plasmid pSGI-YC04.
  • Plasmid pSG1-YC04 was introduced into S. elongatus strain SGC-YC1-2, which harbors a copy of trcE::ChFatB2-7942 integrated into NS1 (see Example 1). The resulting strain was designated SGC-YC4-7. Fatty acid production assays and GC analyses were performed as described in Example 1. The results of GC analyses indicating the levels of FFAs in cultures of various S. elongatus strains 168 hours after IPTG induction are shown in Table 4-1. It is possible that inactivation of the acyl-ACP synthetase gene has a larger impact on secretion of long-chain fatty acids than on secretion of medium-chain fatty acids.
  • PCC 6803 was amplified from genomic DNA using PCR with primers NB001 (SEQ ID NO:23) and NB002 (SEQ ID NO:24). This fragment was cloned into the pCR2.1 vector (Invitrogen) to yield plasmid pSG1-NB3 and subsequently cut with the restriction enzyme Mfe1.
  • a chloramphenicol resistance marker cassette containing the cat gene and associated regulatory control sequences was amplified from plasmid pAM1573 (Andersson, et al., Methods Enzymol . (2000) 305:527-542) to contain flanking Mfe1 restriction sites using PCR with primers NB010 (SEQ ID NO:25) and NB011 (SEQ ID NO:26).
  • the cat gene expression cassette was then inserted into the MfeI site of pSG1-NB3 to yield pSG1-NB5 (SEQ ID NO:27).
  • the pSGI-NB5 vector was transformed into trcE::ChFatB2-7942-containing Synechocystis strain SGC-YC10 ⁇ 5 (see Example 1) according to Zang et al., J Microbiology (2007) 45:241-245. Insertion of the chloramphenicol resistance marker into the Slr1609 gene through homologous recombination was verified by PCR screening of insert and insertion site. The resulting strain was designated SGC-NB10-4, which was tested in liquid BG-11 medium for fatty acid secretion. All liquid medium growth conditions used a rotary shaker (150 rpm) at 30° C. with constant illumination (60 ⁇ E ⁇ m ⁇ 2 ⁇ sec ⁇ 1 ).
  • Free fatty acids were separated from the filtered culture supernatant solutions by liquid-liquid extraction for GC/FID (flame ionization detector) analysis.
  • GC/FID flame ionization detector
  • 2 mL filtered culture was extracted with a mixture of 50 ⁇ l phosphoric acid (1 M), 100 ⁇ l NaCl (5 M) and 2 mL hexane.
  • a 0.2 ⁇ l sample was injected using a 40:1 split ratio on to a DB-FFAP column (J&W Scientific, 15 m ⁇ 250 ⁇ m ⁇ 0.25 ⁇ m), with a temperature profile starting at 150° C. for 0.5 min, then heating at 15° C./min to 230° C. and holding for 7.1 min (1.1 mL/min He).
  • a DNA fragment comprising a functional operon was synthesized such that it contained the following elements in the given order: the trc promoter, the Cuphea lanceolata 3-ketoacyl-acyl carrier protein synthase IV gene (ClKas-IV, GenBank Accession No. CAC59946) codon-optimized for expression in Synechococcus elongatus PCC 7942, and the rps14 terminator (SEQ ID NO:28) from Synechococcus sp. WH8102.
  • the nucleotide sequence of this entire functional operon, along with various flanking restriction enzyme recognition sites, is provided in SEQ ID NO:29.
  • Another DNA fragment comprising a functional operon was synthesized such that it contained the following elements in the given order: the trc promoter, the Helianthus annuus 3-ketoacyl-acyl carrier protein synthase III gene (HaKas-III, GenBank Accession No. ABP93352) codon-optimized for expression in both Synechococcus elongatus PCC 7942 and Synechocystis sp. PCC 6803, and rps14 terminator from Synechococcus sp. WH8102.
  • the nucleotide sequence of this functional operon, along with various flanking restriction enzyme recognition sites, is provided in SEQ ID NO:30.
  • Codon optimization was performed by the use of the “Gene Designer” (version 1.1.4.1) software program provided by DNA2.0, Inc.
  • the functional operon (expression cassette) containing the codon-modified ClKas-IV gene as represented in SEQ ID NO:29 was digested by the restriction enzymes SpeI and XbaI and inserted into plasmid pSGI-YC39 between the restriction sites SpeI and XbaI to form plasmid pSGI-BL26, which enables integration of the functional operon into the Synechocystis sp. PCC 6803 chromosome at the “RS2” recombination site (Aoki, et al., J. Bacteriol (1995) 177:5606-5611).
  • the plasmid pSGI-BL27 containing the DNA fragment represented in SEQ ID NO:30 was constructed in the same way.
  • Plasmid pSGI-BL43 contains the trcE promoter, the codon-optimized ClKas-IV gene, and the rps14 terminator as represented in SEQ ID NO:31 and was made by inserting a SpeI/NcoI trcE fragment from pTrcHis A (Invitrogen) into SpeI/NcoI-digested pSGI-BL26.
  • An additional plasmid, pSGI-BL44 contains the trcE promoter, the optimized ClKas-IV gene, the S.
  • elongatus PCC 7942 kaiBC intergenic region, the optimized HaKas-III gene, and the rps14 terminator as represented in SEQ ID NO:32 and was made by inserting a BamHI/SacI fragment (containing the S. elongatus kaiBC intergenic region, the HaKas-III gene, and the rps14 terminator) generated via PCR amplification into BglII/SacI-digested pSGI-BL43.
  • the PCR primers used to generate the DNA fragment containing the kaiBC region, HaKas-III, and rps14 terminator are provided as SEQ ID NO:33 and SEQ ID NO:34.
  • Wild-type Synechocystis PCC 6803 cells and transgenic Synechocystis strain SGC-YC10-5, which contains the ChFatB2-7942 gene, were transformed with plasmids pSG1-BL26, pSG1-BL27, pSG1-BL43 and pSG1-BL44 as described by Zang, X. et al. J. Microbiol. (2007) 45:241-245. Both recombinant and wild-type control strains were pre-cultivated in 20 mL of BG-11 medium to mid-log phase (OD 730 nm 0.7 ⁇ 0.9) on a rotary shaker (150 rpm) at 30° C.
  • Results indicating the levels of secreted octanoic acid and decanoic acid in culture supernatants 144 hours after culture inoculation are shown in Table 6-1.
  • the ClKas-IV and HaKas-III genes present in the indicated strains were under the control of the trc promoter.
  • a synthetic gene that encodes a derivative of the ChFatB2 enzyme with specificity for medium-chain (8:0-10:0) acyl-ACPs is expressed in various diatoms (Bacillariophyceae) by constructing and utilizing expression vectors comprising the ChFatB2 gene operably linked to gene regulatory regions (promoters and terminators) that function in diatoms.
  • the gene is optimized for expression in specific diatom species and the portion of the gene that encodes the plastid transit peptide region of the native ChFatB2 protein is replaced with a plastid transit peptide that functions optimally in diatoms.
  • the protein encoded by this gene referred to hereafter as ChFatB2-Thal, is provided in SEQ ID NO:36.
  • the ChFatB2-Thal gene was placed between the T. pseudonana alpha-tubulin promoter and terminator regulatory sequences.
  • the alpha-tubulin promoter was amplified from genomic DNA isolated from T. pseudonana CCMP 1335 by use of primers PR1 (SEQ ID NO:37) and PR3 (SEQ ID NO:38), whereas the alpha-tubulin terminator was amplified by use of primers PR4 (SEQ ID NO:39) and PR8 (SEQ ID NO:40).
  • the KpnI/BamHI fragment from the alpha-tubulin promoter amplicon, the BamHI/XbaI fragment from the alpha-tubulin terminator and the large fragment from KpnI/XbaI-cut pUC118 were then combined to form pSG1-PR5.
  • the NcoI/BamHI fragment from ChFatB2-Thal gene was then inserted into NcoI/BamHI-digested pSG1-PR5 to form pSG1-PR16.
  • NAT nourseothricin acetyltransferase
  • pSGI-PR16 and pSGI-PR7 were co-transformed into T. pseudonana CCMP 1335 by means of particle bombardment essentially as described by Poulsen, et al., ( J. Phycol . (2006) 42:1059-1065). Transformed cells were selected on agar plates in the presence of 100 mg/L nourseothricin (ClonNAT, obtained from Werner BioAgents, Germany). The presence of the ChFatB2-Thal gene in cells was confirmed by the use of PCR. Transformants were grown in ASW liquid medium (Darley and Volcani, Exp. Cell Res . (1964) 58:334) on a rotary shaker (150 rpm) at 18° C. with constant illumination (60 ⁇ E ⁇ m ⁇ 2 ⁇ sec ⁇ 1 ). Samples were removed seven days after inoculation and the culture medium was tested for the presence of FFAs as described in Example 1.
  • a synthetic gene that encodes a derivative of the ChFatB2 enzyme with specificity for medium-chain (8:0-10:0) acyl-ACPs is expressed in green algae (Chlorophyceae) by constructing and utilizing expression vectors comprising the ChFatB2 gene operably linked to gene regulatory regions (promoters and terminators) that function in green algae.
  • the gene is optimized for expression in specific green algal species and the portion of the gene that encodes the plastid transit peptide region of the native ChFatB2 protein is replaced with a plastid transit peptide that functions optimally in green algae.
  • the nucleotide sequence provided as SEQ ID NO:42 represents a derivative of the ChFatB2 gene optimized for expression in Chlamydomonas reinhardtii and in which the native plastid transit peptide-encoding region of the gene has been replaced with the plastid transit peptide associated with the gamma subunit of the coupling factor portion (CF1) of the chloroplast ATP synthase from C. reinhardtii (GenPept Accession No. XP 001696335).
  • the protein encoded by this gene is provided in SEQ ID NO:43.
  • a 1.4-kbp DNA fragment spanning an area upstream and into the coding region of the 1,4-alpha-glucan branching enzyme gene (glgB, Cyanobase gene designation s110158) from Synechocystis sp.
  • PCC6803 was amplified from genomic DNA using PCR with primers glgB-5 (SEQ ID NO:44) and glgB-3 (SEQ ID NO:45). This fragment was cloned into the pCR4-Topo vector (Invitrogen) to yield plasmid pSGI-BL32 and subsequently cut with the restriction enzyme AvaI.
  • a spectinomycin resistance marker cassette containing the aadA gene and associated regulatory control sequences was digested by HindIII from plasmid pSGI-BL27. Both of the linear fragments were treated with the Quick BluntingTM Kit (New England Biolabs). The aadA gene expression cassette was then inserted into the AvaI site of pSGI-BL32 to yield pSGI-BL33. The portion of pSGI-BL33 that inserts into and inactivates the glgB gene is provided as SEQ ID NO:46).
  • the pSGI-BL33 vector was transformed into wild-type Synechocystis PCC 6803 and into trcE::ChFatB2-7942-containing Synechocystis strain SGC-YC10-5 (see Example 1) according to Zang, et al., J. Microbiology (2007) 45:241-245. Insertion of the spectinomycin resistance marker into the S110158 (glgB) gene via homologous recombination was verified by PCR screening of insert and insertion site. Verified knockout strains were tested in liquid BG-11 medium for secretion of fatty acids. All liquid medium growth conditions used a rotary shaker (150 rpm) at 30° C.
  • Free fatty acids were separated from the filtered culture supernatant solutions by liquid-liquid extraction for GC/FID analysis.
  • 2 mL of filtered culture were extracted with a mixture of 50 ⁇ L phosphoric acid (1 M), 100 ⁇ L NaCl (5 M) and 2 mL hexane.
  • a 0.2 ⁇ l sample was injected using a 40:1 split ratio on to a DB-FFAP column (J&W Scientific, 15 m ⁇ 250 ⁇ m ⁇ 0.25 ⁇ m), with a temperature profile starting at 150° C. for 0.5 min, then heating at 15° C./min to 230° C. and holding for 7.1 min (1.1 mL/min He).
  • a spike solution was formulated by dissolving 75 mg/L octanoic acid and 75 mg/L decanoic acid in BG-11 medium supplemented with 300 mM NaCl and adjusting the pH to 5.8. 50 mg of each of the resins listed in Table 1 were weighed into a 50 mL centrifuge tube and combined with 1.0 mL of methanol and shaken gently. The excess methanol was decanted and the resins were dried under a 25 in Hg vacuum, room temperature, overnight. 50 mL of the spike solution was then added to each of the resins and incubated with gentle shaking at 31° C. for 24 hours.
  • Adsorption Capacity (mg/g) Octanoic Decanoic Total free Description Resin type Acid acid fatty acids Dowex Optipore ® Post cross-linked macroporous 26.3 69.8 96.0 V503 (Dow Chemical) polystyrene divinyl benzene Lewatit 1064 MD Macroporous polystyrene 1.1 46.7 47.8 (LanXess) divinyl benzene Zeolyst CBV 28014 Very low-alumina zeolite 17.4 74.7 92.0 (Zeolyst) Zeolyst CBV 901 Low-alumina zeolite 5.4 64.8 70.1 (Zeolyst) Hisiv 3000 Silicalite Hydrophobic silicalite 15.3 23.7 39.1 (UOP Honeywell) Lipidex 5000 (Packard Alkylated sephadex gel 0.00 18.6 18.6 Instrument Co.) Norit ROW
  • Synechocystis sp. strain SGC-YC10-5 which contains the ChFatB2-7942 gene as described in Example 1, was cultured in BG-11 with and without Dowex® Optipore® V503 resin. 400 mL of fresh culture was induced with 5 mM IPTG and incubated at room temperature for 1 hour to allow for uptake of the inducer. The culture was then divided into four 1,000 mL baffled Erlenmeyer flasks with PTFE vent caps. To two of the flasks, approximately 400 mg of Dowex® Optipore® V503 were added. The adsorbent resin in the test flasks was recovered and exchanged for fresh resin daily for 10 days.
  • the recovered resin was washed liberally with deionized water and eluted with 2 mL of methanol. Samples of culture medium from the test flasks and control flasks were also taken daily. The samples were measured for OD 730 nm and filtered over a Whatman® GF/B glass fiber filter and analyzed for octanoic acid and decanoic acid content by gas chromatography as previously described in Example 2. The results are presented in Table 11-1.
  • Table 10-3 above reveals a clear relationship between free fatty acid adsorption capacity and pH. This relationship results from the inefficiency of extraction of the ionized form of the free fatty acids. Many potential production hosts require a pH significantly higher than the pKa of free fatty acids in order to survive and reproduce. An extreme example of this would be the alkalophilic cyanobacteria such as those belonging to the genera Synechococcus, Synechocystis, Spirulina , and many others, which prefer a pH between 9 and 11 for optimum growth.
  • the CO 2 -enriched, free fatty acid-depleted suspension is then returned to the bulk culture.
  • the pressure inside the gas-liquid contactor can be controlled independently to provide a constant pH in the stream exiting the adsorption column. Further, the pressure of the post-column flash vessel can be controlled so as to provide a supply of CO 2 which is titrated to the CO 2 consumption rate of the bulk culture through PID control of pH, dissolved CO 2 , off-gas CO 2 , or any combination of the three. The excess CO 2 can then be recycled.
  • Vessel E-1 was filled with 4L of a spike solution containing 700 mg/L octanoic acid dissolved in 100 mM NaCl, pH 11.1.
  • Column C1 was filled with 45.2 g of Dowex® Optipore® V503 polymeric resin. The resin was activated with two column volumes of methanol, followed by a wash of three column volumes of 100 mM NaCl, pH 11.1.
  • Liquid-gas contact vessel E2 was then filled with 200 mL of spike solution and 34.7 psia of CO 2 .
  • peristaltic pumps P-1 and P-2 were set to the same flow rate and column loading was initiated. Valve V-2 was adjusted as needed to increase the column pressure and prevent the formation of gas bubbles.
  • a synthetic gene that encodes a derivative of a FatA-type plant acyl-ACP TE enzyme with specificity for oleoyl-ACP is expressed in various photosynthetic microorganisms by constructing and utilizing expression vectors comprising a FatA gene operably linked to gene regulatory regions (promoters and terminators) that function in the host photosynthetic microorganism.
  • the gene is optimized for expression in the host photosynthetic microorganism and the portion of the gene that encodes the plastid transit peptide region of the native FatA protein is removed for expression in cyanobacteria or replaced with a plastid transit peptide that functions effectively in the host eukaryotic photosynthetic microorganisms.
  • Genes that could be used for this purpose include, but are not limited to, those that encode the following acyl-ACP TEs (referred to by GenPept Accession Numbers): NP — 189147.1, AAC49002, CAA52070.1, CAA52069.1, 193041.1, CAC39106, CAO17726, AAC72883, AAA33020, AAL79361, AAQ08223.1, AAB51523, AAL77443, AAA33019, AAG35064, and AAL77445.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
US12/333,280 2007-12-11 2008-12-11 Secretion of fatty acids by photosynthetic microorganisms Abandoned US20090298143A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/333,280 US20090298143A1 (en) 2007-12-11 2008-12-11 Secretion of fatty acids by photosynthetic microorganisms
US13/340,350 US10233470B2 (en) 2007-12-11 2011-12-29 Secretion of fatty acids by photosynthetic microorganisms

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US733307P 2007-12-11 2007-12-11
US12/333,280 US20090298143A1 (en) 2007-12-11 2008-12-11 Secretion of fatty acids by photosynthetic microorganisms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/340,350 Division US10233470B2 (en) 2007-12-11 2011-12-29 Secretion of fatty acids by photosynthetic microorganisms

Publications (1)

Publication Number Publication Date
US20090298143A1 true US20090298143A1 (en) 2009-12-03

Family

ID=40755894

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/333,280 Abandoned US20090298143A1 (en) 2007-12-11 2008-12-11 Secretion of fatty acids by photosynthetic microorganisms
US13/340,350 Expired - Fee Related US10233470B2 (en) 2007-12-11 2011-12-29 Secretion of fatty acids by photosynthetic microorganisms

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/340,350 Expired - Fee Related US10233470B2 (en) 2007-12-11 2011-12-29 Secretion of fatty acids by photosynthetic microorganisms

Country Status (10)

Country Link
US (2) US20090298143A1 (enExample)
EP (1) EP2231864B1 (enExample)
JP (1) JP5465183B2 (enExample)
CN (1) CN101952452B (enExample)
AU (1) AU2008335089B2 (enExample)
BR (1) BRPI0821508B1 (enExample)
MX (1) MX2010006539A (enExample)
MY (1) MY154028A (enExample)
WO (1) WO2009076559A1 (enExample)
ZA (1) ZA201004253B (enExample)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080152636A1 (en) * 2006-09-08 2008-06-26 Kaneka Corporation Composition containing reduced coenzyme Q10 and lysolecithin
US20090295140A1 (en) * 2006-10-24 2009-12-03 Flynn Timothy J Label assembly for applying a label to an object
US20100081178A1 (en) * 2008-10-23 2010-04-01 Targeted Growth, Inc. Modified photosynthetic microorganisms for producing triglycerides
US20100184169A1 (en) * 2008-12-23 2010-07-22 Targeted Growth, Inc. Modified Photosynthetic Microorganisms With Reduced Glycogen and Their Use in Producing Carbon-Based Products
US20110020883A1 (en) * 2009-06-29 2011-01-27 Synthetic Genomics, Inc. Acyl-acp thioesterase genes and uses therefor
US20120094338A1 (en) * 2008-07-22 2012-04-19 Li zhong kui Continuous production and excretion of waxy products from photosynthetic organisms
WO2012087675A1 (en) 2010-12-23 2012-06-28 Exxonmobil Research And Engineering Company Culturing a microorganism in a medium with an elevated level of a carboxylate counterion source
WO2012087673A1 (en) * 2010-12-23 2012-06-28 Exxonmobil Research And Engineering Company Prokaryotic acyl-acp thioesterases for producing fatty acids in genetically engineered microorganisms
WO2012135668A1 (en) 2011-03-31 2012-10-04 Exxonmobil Research And Engineering Company Metabolic pathway targeting by transcription factor overexpression
WO2013003608A1 (en) * 2011-06-28 2013-01-03 Brookhaven Science Associates, Llc Modified plants with increased oil content
WO2013049423A1 (en) 2011-09-27 2013-04-04 Synthetic Genomics, Inc. Production and secretion of fatty acids and fatty acid derivatives
WO2013126076A1 (en) 2012-02-24 2013-08-29 Exxonmobil Research And Engineering Company Enhanced production of fatty acids and fatty acid derivatives by recombinant microorganisms
US20130267012A1 (en) * 2010-11-22 2013-10-10 The Regents Of The University Of California Host Cells and Methods for Producing Diacid Compounds
WO2013162648A1 (en) 2012-04-23 2013-10-31 Exxonmobil Research And Engineering Company Cell systems and methods for improving fatty acid synthesis by expression of dehydrogenases
US8883993B2 (en) * 2012-12-04 2014-11-11 Exxonmobil Research And Engineering Company Tetraselmis promoters and terminators for use in eukaryotic cells
US8951762B2 (en) 2011-07-27 2015-02-10 Iowa State University Research Foundation, Inc. Materials and methods for using an acyl—acyl carrier protein thioesterase and mutants and chimeras thereof in fatty acid synthesis
US8962299B2 (en) 2012-02-29 2015-02-24 Exxonmobil Research And Engineering Company Four-gene pathway for wax ester synthesis
US8975061B2 (en) 2011-06-30 2015-03-10 Exxonmobil Research And Engineering Company Regulation of toxin and antitoxin genes for biological containment
US8980613B2 (en) 2010-04-06 2015-03-17 Matrix Genetics, Llc Modified photosynthetic microorganisms for producing lipids
US9096834B2 (en) 2012-02-24 2015-08-04 Exxonmobil Research And Engineering Company Recombinant microorganisms comprising thioesterase and lysophosphatidic acid acyltransferase genes for fatty acid production
US9359623B2 (en) 2009-07-24 2016-06-07 The Regents Of The University Of California Methods and compositions for the production of fatty acids in photosynthetic prokaryotic microorganisms
US9399768B2 (en) 2011-07-27 2016-07-26 Iowa State University Research Foundation, Inc. Materials and methods for using an acyl-acyl carrier protein thioesterase and mutants and chimeras thereof in fatty acid synthesis
US9909155B2 (en) 2012-04-18 2018-03-06 Corbion Biotech, Inc. Structuring fats and methods of producing structuring fats
US9969990B2 (en) 2014-07-10 2018-05-15 Corbion Biotech, Inc. Ketoacyl ACP synthase genes and uses thereof
US10006066B2 (en) 2014-01-31 2018-06-26 Kao Corporation Modified cyanobacteria
US10006034B2 (en) 2010-05-28 2018-06-26 Corbion Biotech, Inc. Recombinant microalgae including keto-acyl ACP synthase
US10053715B2 (en) 2013-10-04 2018-08-21 Corbion Biotech, Inc. Tailored oils
US10100341B2 (en) 2011-02-02 2018-10-16 Corbion Biotech, Inc. Tailored oils produced from recombinant oleaginous microorganisms
US10167489B2 (en) 2010-11-03 2019-01-01 Corbion Biotech, Inc. Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
US10233470B2 (en) 2007-12-11 2019-03-19 Synthetic Genomics, Inc. Secretion of fatty acids by photosynthetic microorganisms
US10287612B2 (en) 2014-12-22 2019-05-14 Kao Corporation Modified cyanobacteria
US10508292B2 (en) * 2015-05-22 2019-12-17 Kao Corporation Method of producing lipid
US10724046B2 (en) 2015-09-11 2020-07-28 Kao Corporation Method of producing lipid
US10801044B2 (en) 2017-02-08 2020-10-13 Kao Corporation Method of producing fatty alcohol
US10995348B2 (en) 2016-05-10 2021-05-04 Kao Corporation Method of producing lipid
US12252513B2 (en) 2018-07-16 2025-03-18 Lumen Bioscience, Inc. Thermostable phycobiliproteins produced from recombinant arthrospira
US12447202B2 (en) 2018-05-17 2025-10-21 Lumen Bioscience, Inc. Arthrospira platensis oral vaccine delivery platform

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101504618B1 (ko) 2007-06-01 2015-03-23 솔라짐, 인코포레이티드 미생물에서 오일의 생성
US8048654B2 (en) 2010-06-09 2011-11-01 Joule Unlimited Technologies, Inc. Methods and compositions for the recombinant biosynthesis of fatty acids and esters
AU2013201607B2 (en) * 2008-04-28 2015-03-12 Naturally Scientific Technologies Limited Production of biofuel from tissue culture sources
GB0807619D0 (en) * 2008-04-28 2008-06-04 Whitton Peter A Production of bio fuels from plant tissue culture sources
US20100303989A1 (en) 2008-10-14 2010-12-02 Solazyme, Inc. Microalgal Flour
ES2583639T3 (es) 2008-11-28 2016-09-21 Terravia Holdings, Inc. Producción de aceites específicos en microorganismos heterótrofos
JP2011246605A (ja) * 2010-05-26 2011-12-08 Hitachi Plant Technologies Ltd バイオ燃料製造方法
US20130040340A1 (en) 2011-02-07 2013-02-14 E. I. Du Pont De Nemours And Company Production of alcohol esters in situ using alcohols and fatty acids produced by microorganisms
AU2012253803A1 (en) 2011-05-06 2013-12-05 Terravia Holdings, Inc. Genetically engineered microorganisms that metabolize xylose
DE102011110945A1 (de) 2011-08-15 2013-02-21 Evonik Degussa Gmbh Biotechnologisches Syntheseverfahren von organischen Verbindungen mit alkIL-Genprodukt
DE102011110946A1 (de) 2011-08-15 2016-01-21 Evonik Degussa Gmbh Biotechnologisches Syntheseverfahren von omegafunktionalisierten Carbonsäuren und Carbonsäure-Estern aus einfachen Kohlenstoffquellen
US9719114B2 (en) 2012-04-18 2017-08-01 Terravia Holdings, Inc. Tailored oils
US10098371B2 (en) 2013-01-28 2018-10-16 Solazyme Roquette Nutritionals, LLC Microalgal flour
EP2993993A2 (en) 2013-04-26 2016-03-16 Solazyme, Inc. Low polyunsaturated fatty acid oils and uses thereof
DE102013208228A1 (de) 2013-05-06 2014-11-06 Siemens Aktiengesellschaft Verfahren zum Kultivieren eines Mikroorganismus in einer in vitro Kultur und Verfahren zum Herstellen eines Sekundärmetabolits
FR3009619B1 (fr) 2013-08-07 2017-12-29 Roquette Freres Compositions de biomasse de microalgues riches en proteines de qualite sensorielle optimisee
WO2015149026A1 (en) 2014-03-28 2015-10-01 Solazyme, Inc. Lauric ester compositions
KR101735632B1 (ko) * 2014-12-10 2017-05-16 한국과학기술연구원 시아노박테리아 발현 벡터
EP3377057A4 (en) 2016-01-07 2018-12-05 Conagen Inc. Methods of making capsinoids by biosynthetic processes
US10418697B2 (en) * 2016-02-25 2019-09-17 Toshiba Client Solutions Co. Ltd. Antenna apparatus and electronic device
DK3487986T3 (da) 2016-07-19 2021-07-26 Conagen Inc Fremgangsmåde til mikrobiel fremstilling af specifikke naturlige capsaicinoider
JP6971607B2 (ja) * 2016-12-19 2021-11-24 花王株式会社 脂質の製造方法
CN110291194B (zh) * 2016-12-22 2024-11-22 科纳根公司 用于微生物生产8-甲基壬酸的方法
JP7551990B2 (ja) * 2020-08-28 2024-09-18 大成建設株式会社 遊離脂肪酸の分離方法と回収方法
US11336975B1 (en) 2021-02-01 2022-05-17 Shure Acquisition Holdings, Inc. Wearable device with detune-resilient antenna
JP7646964B2 (ja) * 2021-08-20 2025-03-18 大成建設株式会社 遊離脂肪酸の回収方法、回収システム
GB2617381A (en) 2022-04-07 2023-10-11 Phycobloom Ltd Engineered photosynthetic organisms

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179219A (en) * 1990-11-19 1993-01-12 Uop Process for separating fatty acids and triglycerides
US5298421A (en) * 1990-04-26 1994-03-29 Calgene, Inc. Plant medium-chain-preferring acyl-ACP thioesterases and related methods
US6150512A (en) * 1995-05-15 2000-11-21 Yuan; Ling Engineering plant thioesterases and disclosure of plant thioesterases having novel substrate specificity
US6495140B1 (en) * 1998-01-12 2002-12-17 Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada Process for the isolation, recovery and purification of non-polar extractives
US20040111763A1 (en) * 2000-02-09 2004-06-10 Ernst Heinz Novel elongase gene and method for producing multiple-unsaturated fatty acids
US20040197882A1 (en) * 1999-07-07 2004-10-07 Chiaki Saitoh Process for producing hydroxylated fatty acids and delta-lactones
US20050191679A1 (en) * 2004-02-13 2005-09-01 Martek Biosciences Corporation Schizochytrium fatty acid synthase (FAS) and products and methods related thereto
US20060117414A1 (en) * 2000-09-28 2006-06-01 Bioriginal Food & Science Corp. Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof
US20070087420A1 (en) * 2005-10-19 2007-04-19 Macool Daniel J Mortierella alpina C16/18 fatty acid elongase
US20080182308A1 (en) * 2005-09-29 2008-07-31 Donaldson Gail K Fermentive production of four carbon alcohols

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455167A (en) 1991-05-21 1995-10-03 Calgene Inc. Medium-chain thioesterases in plants
JP2729883B2 (ja) * 1992-10-07 1998-03-18 工業技術院長 藍藻を用いる有機分泌物の製造方法
DK0963439T3 (da) 1997-02-19 2007-09-03 Enol Energy Inc Genmanipulerede Cyanobakterier til fremstilling af ethanol
EP1752532A1 (en) 2005-08-09 2007-02-14 Helmholtz-Zentrum für Infektionsforschung GmbH Extracellular polyhydroxyalkanoates produced by genetically engineered microorganisms
EP2157170B1 (en) * 2006-05-19 2014-01-15 LS9, Inc. Production of fatty acids and derivatives thereof
BRPI0809345A2 (pt) * 2007-03-28 2014-10-07 Ls9 Inc Células recombinantes, composições produzidas por estas, métodos para produzir derivados de ácidos graxos em uma célula recombinante, para aumentar a produção de derivados de ácidos graxos em uma célula recombinante, construto recombinante, vetores, métodos para aumentar a produção de derivados de ácidos graxos em uma célula hospedeira de produção, para produzir derivados de ácidos graxos, derivados de ácidos graxos, composições de biocombustível.
KR101504618B1 (ko) 2007-06-01 2015-03-23 솔라짐, 인코포레이티드 미생물에서 오일의 생성
CN101952452B (zh) 2007-12-11 2014-07-09 合成基因组公司 通过光合微生物分泌脂肪酸
US20110218354A1 (en) 2008-09-19 2011-09-08 President And Fellows Of Harvard College Photoautotrophic Adipogenesis Technology (Phat)

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298421A (en) * 1990-04-26 1994-03-29 Calgene, Inc. Plant medium-chain-preferring acyl-ACP thioesterases and related methods
US5179219A (en) * 1990-11-19 1993-01-12 Uop Process for separating fatty acids and triglycerides
US6150512A (en) * 1995-05-15 2000-11-21 Yuan; Ling Engineering plant thioesterases and disclosure of plant thioesterases having novel substrate specificity
US6495140B1 (en) * 1998-01-12 2002-12-17 Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada Process for the isolation, recovery and purification of non-polar extractives
US20040197882A1 (en) * 1999-07-07 2004-10-07 Chiaki Saitoh Process for producing hydroxylated fatty acids and delta-lactones
US20040111763A1 (en) * 2000-02-09 2004-06-10 Ernst Heinz Novel elongase gene and method for producing multiple-unsaturated fatty acids
US20060117414A1 (en) * 2000-09-28 2006-06-01 Bioriginal Food & Science Corp. Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof
US20050191679A1 (en) * 2004-02-13 2005-09-01 Martek Biosciences Corporation Schizochytrium fatty acid synthase (FAS) and products and methods related thereto
US20080182308A1 (en) * 2005-09-29 2008-07-31 Donaldson Gail K Fermentive production of four carbon alcohols
US20070087420A1 (en) * 2005-10-19 2007-04-19 Macool Daniel J Mortierella alpina C16/18 fatty acid elongase

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Bhattacharyya et al., Cell 60:115-122, 1990 *
Lem et al., Plant Physiology 74:134-138, 1984 *
Webster's Ninth New Collegiate Dictionary, 1985, page 1176 *
Welker et al., FEMS Microbiology Reviews 30(4):530-563, 2006 *
Yoo et al., Carbohydrate Research 337:2195-2203, 2002 *

Cited By (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080152636A1 (en) * 2006-09-08 2008-06-26 Kaneka Corporation Composition containing reduced coenzyme Q10 and lysolecithin
US20090295140A1 (en) * 2006-10-24 2009-12-03 Flynn Timothy J Label assembly for applying a label to an object
US10233470B2 (en) 2007-12-11 2019-03-19 Synthetic Genomics, Inc. Secretion of fatty acids by photosynthetic microorganisms
US20120094338A1 (en) * 2008-07-22 2012-04-19 Li zhong kui Continuous production and excretion of waxy products from photosynthetic organisms
US20100081178A1 (en) * 2008-10-23 2010-04-01 Targeted Growth, Inc. Modified photosynthetic microorganisms for producing triglycerides
US9029120B2 (en) 2008-10-23 2015-05-12 Matrix Genetics, Llc Modified photosynthetic microorganisms for producing triglycerides
US8394621B2 (en) 2008-10-23 2013-03-12 Matrix Genetrics, LLC Modified photosynthetic microorganisms for producing triglycerides
US8394614B2 (en) 2008-10-23 2013-03-12 Matrix Genetics, Llc Modified photosynthetic microorganisms for producing triglycerides
US20100184169A1 (en) * 2008-12-23 2010-07-22 Targeted Growth, Inc. Modified Photosynthetic Microorganisms With Reduced Glycogen and Their Use in Producing Carbon-Based Products
US8835137B2 (en) 2008-12-23 2014-09-16 Matrix Genetics, Llc Modified photosynthetic microorganisms with reduced glycogen and their use in producing carbon-based products
US20110020883A1 (en) * 2009-06-29 2011-01-27 Synthetic Genomics, Inc. Acyl-acp thioesterase genes and uses therefor
US8956834B2 (en) 2009-06-29 2015-02-17 Synthetic Genomics, Inc. Acyl-ACP thioesterase genes and uses therefor
US9920340B2 (en) 2009-06-29 2018-03-20 Synthetic Genomics, Inc. Acyl-ACP thioesterase genes and uses therefor
US9359623B2 (en) 2009-07-24 2016-06-07 The Regents Of The University Of California Methods and compositions for the production of fatty acids in photosynthetic prokaryotic microorganisms
US8980613B2 (en) 2010-04-06 2015-03-17 Matrix Genetics, Llc Modified photosynthetic microorganisms for producing lipids
US10006034B2 (en) 2010-05-28 2018-06-26 Corbion Biotech, Inc. Recombinant microalgae including keto-acyl ACP synthase
US10344305B2 (en) 2010-11-03 2019-07-09 Corbion Biotech, Inc. Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
US10167489B2 (en) 2010-11-03 2019-01-01 Corbion Biotech, Inc. Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
US9951345B2 (en) * 2010-11-22 2018-04-24 The Regents Of The University Of California Host cells and methods for producing diacid compounds
US20130267012A1 (en) * 2010-11-22 2013-10-10 The Regents Of The University Of California Host Cells and Methods for Producing Diacid Compounds
US8530207B2 (en) 2010-12-23 2013-09-10 Exxonmobil Research And Engineering Company Photosynthetic microorganisms comprising exogenous prokaryotic acyl-ACP thioesterases and methods for producing fatty acids
US20120184002A1 (en) * 2010-12-23 2012-07-19 Exxonmobil Research And Engineering Company Culturing a microorganism in a medium with an elevated level of a carboxylate counterion source
US9187726B2 (en) * 2010-12-23 2015-11-17 Exxonmobil Research And Engineering Company Culturing a microorganism in a medium with an elevated level of a carboxylate counterion source
WO2012087673A1 (en) * 2010-12-23 2012-06-28 Exxonmobil Research And Engineering Company Prokaryotic acyl-acp thioesterases for producing fatty acids in genetically engineered microorganisms
US9175256B2 (en) 2010-12-23 2015-11-03 Exxonmobil Research And Engineering Company Production of fatty acids and fatty acid derivatives by recombinant microorganisms expressing polypeptides having lipolytic activity
WO2012087675A1 (en) 2010-12-23 2012-06-28 Exxonmobil Research And Engineering Company Culturing a microorganism in a medium with an elevated level of a carboxylate counterion source
US10100341B2 (en) 2011-02-02 2018-10-16 Corbion Biotech, Inc. Tailored oils produced from recombinant oleaginous microorganisms
US9040264B2 (en) 2011-03-31 2015-05-26 Exxonmobil Research And Engineering Company Recombinant cyanobacterium expressing a transcription factor domain protein
WO2012135668A1 (en) 2011-03-31 2012-10-04 Exxonmobil Research And Engineering Company Metabolic pathway targeting by transcription factor overexpression
WO2013003608A1 (en) * 2011-06-28 2013-01-03 Brookhaven Science Associates, Llc Modified plants with increased oil content
CN103813709A (zh) * 2011-06-28 2014-05-21 布鲁克黑文科学联合会 具有增加的油含量的经修饰植物
US8975061B2 (en) 2011-06-30 2015-03-10 Exxonmobil Research And Engineering Company Regulation of toxin and antitoxin genes for biological containment
US9399768B2 (en) 2011-07-27 2016-07-26 Iowa State University Research Foundation, Inc. Materials and methods for using an acyl-acyl carrier protein thioesterase and mutants and chimeras thereof in fatty acid synthesis
US10392606B2 (en) 2011-07-27 2019-08-27 Iowa State University Research Foundation, Inc. Materials and methods for using an acyl-acyl carrier protein thioesterase and mutants and chimeras thereof in fatty acid synthesis
US8951762B2 (en) 2011-07-27 2015-02-10 Iowa State University Research Foundation, Inc. Materials and methods for using an acyl—acyl carrier protein thioesterase and mutants and chimeras thereof in fatty acid synthesis
US9868942B2 (en) 2011-07-27 2018-01-16 Iowa State University Research Foundation, Inc. Materials and methods for using an acyl-acyl carrier protein thioesterase and mutants and chimeras thereof in fatty acid synthesis
US8921090B2 (en) 2011-09-27 2014-12-30 Exxonmobil Research And Engineering Company Acyl-ACP wax ester synthases
WO2013049423A1 (en) 2011-09-27 2013-04-04 Synthetic Genomics, Inc. Production and secretion of fatty acids and fatty acid derivatives
US9017975B2 (en) 2011-09-27 2015-04-28 Synthetic Genomics, Inc. Production and secretion of fatty acids and fatty acid derivatives
US9096834B2 (en) 2012-02-24 2015-08-04 Exxonmobil Research And Engineering Company Recombinant microorganisms comprising thioesterase and lysophosphatidic acid acyltransferase genes for fatty acid production
WO2013126076A1 (en) 2012-02-24 2013-08-29 Exxonmobil Research And Engineering Company Enhanced production of fatty acids and fatty acid derivatives by recombinant microorganisms
US8962299B2 (en) 2012-02-29 2015-02-24 Exxonmobil Research And Engineering Company Four-gene pathway for wax ester synthesis
US9909155B2 (en) 2012-04-18 2018-03-06 Corbion Biotech, Inc. Structuring fats and methods of producing structuring fats
US11401538B2 (en) 2012-04-18 2022-08-02 Corbion Biotech, Inc. Structuring fats and methods of producing structuring fats
US10683522B2 (en) 2012-04-18 2020-06-16 Corbion Biotech, Inc. Structuring fats and methods of producing structuring fats
US10287613B2 (en) 2012-04-18 2019-05-14 Corbion Biotech, Inc. Structuring fats and methods of producing structuring fats
WO2013162648A1 (en) 2012-04-23 2013-10-31 Exxonmobil Research And Engineering Company Cell systems and methods for improving fatty acid synthesis by expression of dehydrogenases
US9181568B2 (en) 2012-04-23 2015-11-10 Exxonmobil Research And Engineering Company Cell systems and methods for improving fatty acid synthesis by expression of dehydrogenases
US8883993B2 (en) * 2012-12-04 2014-11-11 Exxonmobil Research And Engineering Company Tetraselmis promoters and terminators for use in eukaryotic cells
AU2012396282B2 (en) * 2012-12-04 2016-05-19 Exxonmobil Research And Engineering Company Tetraselmis promoters and terminators for use in eukaryotic cells
US10053715B2 (en) 2013-10-04 2018-08-21 Corbion Biotech, Inc. Tailored oils
US10006066B2 (en) 2014-01-31 2018-06-26 Kao Corporation Modified cyanobacteria
US10316299B2 (en) 2014-07-10 2019-06-11 Corbion Biotech, Inc. Ketoacyl ACP synthase genes and uses thereof
US9969990B2 (en) 2014-07-10 2018-05-15 Corbion Biotech, Inc. Ketoacyl ACP synthase genes and uses thereof
US10287612B2 (en) 2014-12-22 2019-05-14 Kao Corporation Modified cyanobacteria
US10508292B2 (en) * 2015-05-22 2019-12-17 Kao Corporation Method of producing lipid
US10724046B2 (en) 2015-09-11 2020-07-28 Kao Corporation Method of producing lipid
US10995348B2 (en) 2016-05-10 2021-05-04 Kao Corporation Method of producing lipid
US10801044B2 (en) 2017-02-08 2020-10-13 Kao Corporation Method of producing fatty alcohol
US12447202B2 (en) 2018-05-17 2025-10-21 Lumen Bioscience, Inc. Arthrospira platensis oral vaccine delivery platform
US12252513B2 (en) 2018-07-16 2025-03-18 Lumen Bioscience, Inc. Thermostable phycobiliproteins produced from recombinant arthrospira

Also Published As

Publication number Publication date
US10233470B2 (en) 2019-03-19
CN101952452B (zh) 2014-07-09
AU2008335089B2 (en) 2014-06-26
MY154028A (en) 2015-04-30
AU2008335089A1 (en) 2009-06-18
BRPI0821508B1 (pt) 2018-12-26
CN101952452A (zh) 2011-01-19
EP2231864A4 (en) 2011-02-02
EP2231864A1 (en) 2010-09-29
ZA201004253B (en) 2011-08-31
WO2009076559A1 (en) 2009-06-18
JP2011505838A (ja) 2011-03-03
MX2010006539A (es) 2011-02-23
US20130005003A1 (en) 2013-01-03
BRPI0821508A2 (pt) 2014-11-04
EP2231864B1 (en) 2017-05-24
JP5465183B2 (ja) 2014-04-09
WO2009076559A8 (en) 2010-05-20

Similar Documents

Publication Publication Date Title
US10233470B2 (en) Secretion of fatty acids by photosynthetic microorganisms
US9920340B2 (en) Acyl-ACP thioesterase genes and uses therefor
CN102300996B (zh) 在异养型微生物中制备特制油
EP2753701B1 (en) Acyl-acp wax ester synthases
US8633002B2 (en) Microbial production of fatty alcohols
US9175256B2 (en) Production of fatty acids and fatty acid derivatives by recombinant microorganisms expressing polypeptides having lipolytic activity
US8962299B2 (en) Four-gene pathway for wax ester synthesis
EP2814972B1 (en) Enhanced production of fatty acids and fatty acid derivatives by recombinant microorganisms
WO2013130062A1 (en) Four-gene pathway for wax ester synthesis

Legal Events

Date Code Title Description
AS Assignment

Owner name: OXFORD FINANCE LLC, VIRGINIA

Free format text: SECURITY INTEREST;ASSIGNOR:SYNTHETIC GENOMICS, INC.;REEL/FRAME:048655/0406

Effective date: 20190307

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE

AS Assignment

Owner name: SGI-DNA, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:OXFORD FINANCE LLC;REEL/FRAME:054372/0822

Effective date: 20201102

Owner name: GENOVIA BIO, LLC, CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:OXFORD FINANCE LLC;REEL/FRAME:054372/0822

Effective date: 20201102

Owner name: SYNTHETIC GENOMICS VACCINES, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:OXFORD FINANCE LLC;REEL/FRAME:054372/0822

Effective date: 20201102

Owner name: GREEN RESOURCES, LLC, CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:OXFORD FINANCE LLC;REEL/FRAME:054372/0822

Effective date: 20201102

Owner name: SYNTHETIC GENOMICS, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:OXFORD FINANCE LLC;REEL/FRAME:054372/0822

Effective date: 20201102